<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">Fifteen H1N1 study registration records were included in the review (Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>: appendix 6) comprising 10 interventional trials and 5 observational studies (2 with treatment efficacy outcomes, and 3 with general acute clinical outcomes) planned during the pandemic. A total of eight different treatments were to be studied: oseltamivir, zanamivir, convalescent plasma, intravenous immunoglobulin, rosuvastatin, sirolimus, Chinese herbs and vitamin supplementation (vitamins A, C and E).
</p>
